Anti-platelet Precision Medicine to Prevent Stroke Early Progression and Recurrence (PRECISE)
NCT03701360 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1199
Last updated 2022-02-17
Summary
This is a pragmatic, multi-center, non-interventional, non-randomized prospective observational study.
Conditions
Sponsors & Collaborators
-
Asan Medical Center
lead OTHER
Principal Investigators
-
Dong-Wha Kang, MD, PhD · Asan Medical Center
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-30
- Primary Completion
- 2021-07-14
- Completion
- 2021-07-14
Countries
- South Korea
Study Locations
More Related Trials
-
COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke
NCT00814268 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Very Early Use of Rosuvastatin in Preventing Recurrence of Ischemic Stroke
NCT01364220 ·Status: TERMINATED ·Phase: PHASE3
-
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
NCT01013532 ·Status: UNKNOWN ·Phase: PHASE4
-
Colchicine for Prevention of Vascular Inflammation in Non-cardio Embolic Stroke
NCT02898610 ·Status: COMPLETED ·Phase: PHASE3
-
Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor Stroke
NCT05910125 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention
NCT03961334 ·Status: RECRUITING ·Phase: PHASE3
-
PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study
NCT02483169 ·Status: UNKNOWN ·Phase: PHASE4
-
Arterial Spin Label Depicted Ischemic Stroke Cohort (ASLIS)
NCT05920902 ·Status: UNKNOWN
-
Secondary Prevention of Small Subcortical Strokes Trial
NCT00059306 ·Status: COMPLETED ·Phase: PHASE3
-
Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction.
NCT00766545 ·Status: COMPLETED ·Phase: PHASE3
-
Levels of Inflammatory Markers in the Treatment of Stroke-An SPS3 Ancillary Study
NCT00579306 ·Status: COMPLETED
-
Antiplatelet Secondary Prevention International Randomised Trial After INtracerebral HaemorrhaGe (ASPIRING)-Pilot Phase
NCT04522102 ·Status: COMPLETED ·Phase: PHASE3
-
Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE)
NCT05155137 ·Status: RECRUITING ·Phase: PHASE3
-
Cognitive Decline and Underlying Mechanisms in Asymptomatic Intracranial Artery Stenosis Patients
NCT05504330 ·Status: RECRUITING
-
Early Administration of Aspirin in Patients With Acute Ischemic Stroke Treated With Systemic Thrombolysis
NCT02921360 ·Status: UNKNOWN ·Phase: NA
-
Overcome Biochemical Aspirin Resistance Through Cilostazol Combination
NCT00446641 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis
NCT06757764 ·Status: RECRUITING ·Phase: PHASE4
-
Pair Antiplatelet THerapy in Ischemic Stroke With Intracranial Artery Stenosis
NCT06243133 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Anticoagulation Using Rivaroxaban on Top of Aspirin in Intracranial Atherosclerotic Stenosis
NCT05700266 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II
NCT00130039 ·Status: COMPLETED ·Phase: PHASE4
-
Cilostazol vs. Aspirin in Acute Non-cardioembolic Stroke With Cerebral mIcrobleeds
NCT06530537 ·Status: RECRUITING ·Phase: PHASE3
-
Prevalence and Consequences of Antiphospholipid Syndrome in Patients Aged 65 and Over With Ischemic Strokes (IS)
NCT07163338 ·Status: RECRUITING ·Phase: NA
-
REstart or STop Antithrombotic Randomised Trial in France
NCT02966119 ·Status: TERMINATED ·Phase: PHASE3
-
Antiphospholipid Antibodies & Osteopontin as Risk Factors for Cerebrovascular Stroke in Young Adults
NCT03561285 ·Status: UNKNOWN
-
Efficacy of Colchicine in Preventing Recurrent Stroke in the Patients With Acute Atherothrombotic Ischemic Stroke During Hospitalization
NCT06102720 ·Status: RECRUITING ·Phase: PHASE4